SuperworthAemetis EPS AMTX
Diluted earnings per share by quarter and over the last twelve months, from 2011.
- Last 12 months, to Jun 30, 2026
- −$0.91
- Latest quarter, Q2 FY26
- −$0.13
- Fiscal year 2025
- −$1.33
Aemetis' earnings per share was −$0.91 over the twelve months to Jun 30, 2026.
In its latest quarter, Q2 FY26, it was −$0.13.
Earnings per share over time
Fiscal year by fiscal year
| Fiscal year | EPS | Change |
|---|---|---|
| FY2025 | −$1.33 | n/a |
| FY2024 | −$1.94 | n/a |
| FY2023 | −$1.32 | n/a |
| FY2022 | −$3.10 | n/a |
| FY2021 | −$1.61 | n/a |
| FY2020 | −$1.74 | n/a |
| FY2016 | −$0.59 | n/a |
| FY2015 | −$0.55 | −810% |
| FY2014 | $0.08 | n/a |
| FY2013 | −$0.33 | n/a |
| FY2012 | −$0.13 | n/a |
| FY2011 | −$0.47 | n/a |
Each fiscal year is the twelve months to its fourth quarter.
Quarter by quarter
| Quarter | Ended | EPS | On a year earlier | Last 12 months |
|---|---|---|---|---|
| Q2 FY26 | −$0.13 | n/a | −$0.91 | |
| Q1 FY26 | −$0.33 | n/a | −$1.19 | |
| Q4 FY25 | −$0.08 | n/a | −$1.33 | |
| Q3 FY25 | −$0.37 | n/a | −$1.57 | |
| Q2 FY25 | −$0.41 | n/a | −$1.58 | |
| Q1 FY25 | −$0.47 | n/a | −$1.83 | |
| Q4 FY24 | −$0.32 | n/a | −$1.94 | |
| Q3 FY24 | −$0.38 | −152% | −$2.26 | |
| Q2 FY24 | −$0.66 | n/a | −$1.15 | |
| Q1 FY24 | −$0.58 | n/a | −$1.17 | |
| Q4 FY23 | −$0.64 | n/a | −$1.32 | |
| Q3 FY23 | $0.73 | n/a | −$1.31 |
Against its peers
Companies in Chemicals - Specialty nearest Aemetis' size, closest first, today.
| Company | EPS, 12 months | Growth |
|---|---|---|
| AMTXAemetis | −$0.91 | |
| ALTOAlto Ingredients | $0.67 | |
| LXFRLuxfer | $0.29 | −68% a year |
| LXULSB Industries | $0.50 | |
| WLKPWestlake Chemical Partners | $1.63 | +9% a year |
| Peer median | $0.58 |
What the EPS figure tells you
Net income divided by diluted shares. The denominator of PE.
One-off charges and gains swing it. The TTM view smooths a single odd quarter.
More on Aemetis
Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.